Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00803803 · ClinicalTrials.gov registry record · Phase 4
Dose, Effects and Characteristics of Pilocarpine
A Phase 4 study, sponsored by Wills Eye.
- Completed
- Registry status
- Phase 4
- Development phase
- 37
- Enrollment target
NCT00803803 is a Phase 4 study that has completed, run by Wills Eye. The registered enrollment target is 37 participants.
The verdict
NCT00803803, a Phase 4 study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this investigation, in which pilocarpine was given in repeated doses, was to evaluate: Part I - the effects of different concentrations of pilocarpine hydrochloride on intraocular pressure. Part II -the effects on intraocular pressure of glaucomatous patients to pilocarpine 2% when given once, twice and four daily. In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.
Interventions
- DRUG Pilocarpine Concentration
- DRUG Pilocarpine Frequency
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 1978-08 |
| Est. Completion | 1979-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00803803
The ClinicalTrials.gov registry entry for NCT00803803 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pilocarpine Concentration is the first listed.
NCT00803803 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00803803 about?
NCT00803803 is a clinical study titled "Dose, Effects and Characteristics of Pilocarpine". The purpose of this investigation, in which pilocarpine was given in repeated doses, was to evaluate: Part I - the effects of different concentrations of pilocarpine hydrochloride on intraocular pressure. Part II -the effects on intraocular pressure of glaucomatous patients to pilocarpine 2% when gi...
What is the current status of trial NCT00803803?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 37 participants. The study started on 1978-08. Estimated completion is 1979-12.
What interventions are being tested in trial NCT00803803?
The interventions under investigation include: Pilocarpine Concentration (DRUG), Pilocarpine Frequency (DRUG).
Who is sponsoring clinical trial NCT00803803?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.